Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Cold Remedy Nasal Spray (Church & Dwight)
- Development stage
- Unknown
- Lead developer
- Church & Dwight
- Administration
- Intranasal
01
Overview
Zicam Cold Remedy Nasal Spray is an over-the-counter, zinc-free homeopathic nasal spray developed by Matrixx Initiatives (acquired by Church & Dwight). It is formulated with plant-derived active ingredients, including *Galphimia glauca*, *Luffa operculata*, and *Sabadilla*, and is designed to shorten the duration of the common cold and provide multi-symptom relief from nasal congestion, runny nose, sneezing, and watery eyes when administered at the first sign of symptoms. The formulation also contains cooling menthol and eucalyptus to soothe nasal passages.
- Brand names
- Zicam Cold Remedy Nasal SprayZicam Cold Remedy No Drip Nasal SprayZicam Nasal Spray
- Other names
- Galphimia glauca + Luffa operculata + Sabadilla
Beyond the preview
Go deeper on Zicam Cold Remedy Nasal Spray (Church & Dwight).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zicam Cold Remedy Nasal Spray (Church & Dwight).